Subscribe

What are you looking for?

Main Menu

明報新聞網

三生製藥建議實物分派蔓迪股份到主板上市

Future Wealths
Future Wealths
20 11 月, 2025
One Min Read
3 Views
0 Comments
三生製藥（1530）公布，就分拆從事專業消費醫藥業務的附屬公司蔓迪股份，蔓迪已於今日向聯交所遞交申請，以實物分派集團持有的蔓迪全部股份，及進行全球發售新股於主板上市。一旦完成分拆上市，集團將不會保留蔓迪任何權益，蔓迪亦不再為其附屬公司。

原文: https://finance.mingpao.com/fin/instantf/20251120/1763651092410/%e4%b8%89%e7%94%9f%e8%a3%bd%e8%97%a5%e5%bb%ba%e8%ad%b0%e5%af%a6%e7%89%a9%e5%88%86%e6%b4%be%e8%94%93%e8%bf%aa%e8%82%a1%e4%bb%bd%e5%88%b0%e4%b8%bb%e6%9d%bf%e4%b8%8a%e5%b8%82

Last Update: 20 11 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept